The Latest Look at PDT and Immune Checkpoints

Area of Science:

• Immunology
• Oncology
• Photochemistry

Background:

• Photodynamic therapy (PDT) offers direct cancer cell elimination and stimulates antitumor immunity.
• PDT influences the expression of immune checkpoints, key regulators of immune responses.
• The interplay between PDT and immune checkpoints is complex and requires further elucidation.

Purpose of the Study:

• To review and analyze recent findings on PDT and immune checkpoints, including inhibitors.
• To identify emerging research directions for enhancing PDT effectiveness in cancer therapy.
• To summarize the impact of PDT on the tumor microenvironment and immune cell activity.

Main Methods:

• A systematic literature search was conducted in PubMed/MEDLINE for original research articles.
• Articles published between January 2023 and March 2024 focusing on PDT and immune checkpoints were included.
• In vitro and in vivo studies investigating PDT's effects on immune checkpoints and combination therapies were prioritized.

Main Results:

• 24 new research papers highlight PDT's modulation of immune checkpoints and its association with immune checkpoint inhibitors (ICIs).
• PDT enhances ICI delivery to tumors and promotes immunogenic cell death, antigen exposure, and immune cell activation.
• Studies show PDT's potential to overcome tumor immunosuppression, improving ICI therapy efficacy.

Conclusions:

• PDT demonstrates a significant ability to modulate immune checkpoints and enhance antitumor immune responses.
• Combining PDT with ICIs and other agents shows promise for more effective cancer treatment.
• Further research is needed to confirm the efficacy of these emerging PDT-based strategies.